New label, same high-quality cancer PBMCs! The product label for Cancer Peripheral Blood Mononuclear Cells, Frozen has been updated from “Full Collection” to “5-19 million cells” to more accurately reflect the cell number provided (in millions). As the product itself and manufacturing procedures have not changed, some inventory with the old name will be shipped during the transition period. For each collection, the measured cell count prior to cryopreservation will be listed on the Certificate of Analysis (CoA).
Request Pricing
Thank you for your interest in this product.
Please provide us with your contact information and your local representative
will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
New label, same high-quality cancer PBMCs! The product label for Cancer Peripheral Blood Mononuclear Cells, Frozen has been updated from “Full Collection” to “5-19 million cells” to more accurately reflect the cell number provided (in millions). As the product itself and manufacturing procedures have not changed, some inventory with the old name will be shipped during the transition period. For each collection, the measured cell count prior to cryopreservation will be listed on the Certificate of Analysis (CoA).
Start immuno-oncology experiments confidently with a reliable supply of ethically sourced, cryopreserved peripheral blood products from donors diagnosed with acute lymphoblastic leukemia (ALL). Options include cancer-sourced frozen peripheral blood mononuclear cells (MNCs or PBMCs) and custom-isolated frozen products such as plasma and serum. We help you get the cells you need with personalized service and flexible delivery times.
Cancer-sourced primary human MNCs are isolated from peripheral blood, leukapheresis, or whole blood samples using density gradient separation or red blood cell lysis and cryopreserved in animal component-free CryoStor® CS10 medium. All peripheral blood products are obtained from donors diagnosed with ALL using Institutional Review Board (IRB)-approved consent forms and protocols. Additional documentation to meet institutional requirements and high-resolution HLA typing (Class I and Class II alleles and CMV status) are available upon request. Sodium heparin (Na-Hep), ethylenediaminetetraacetic acid (EDTA), or acid-citrate-dextrose solution A (ACDA) is added during collection as an anticoagulant.
Contact techsupport@stemcell.com for donor specifications (BMI category, smoking status, ethnicity, etc.). Donors are screened for HIV-1, HIV-2, hepatitis B, and hepatitis C. Certain products are only available in select territories. For more information, browse frequently asked questions (FAQs) on primary cells.
This product is designed for use in the following research area(s) as part
of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we
offer to support each research area.
Diseased Human Peripheral Blood Products, Acute Lymphoblastic Leukemia (ALL)
Quality Statement:
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.
